🇺🇸 IFN-alpha in United States

38 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Gene Mutation — 5 reports (13.16%)
  2. Abdominal Pain — 4 reports (10.53%)
  3. Arthralgia — 4 reports (10.53%)
  4. Fatigue — 4 reports (10.53%)
  5. Maternal Exposure During Pregnancy — 4 reports (10.53%)
  6. Nausea — 4 reports (10.53%)
  7. Rash — 4 reports (10.53%)
  8. Arteriosclerosis — 3 reports (7.89%)
  9. Asthenia — 3 reports (7.89%)
  10. Atrial Fibrillation — 3 reports (7.89%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is IFN-alpha approved in United States?

IFN-alpha does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for IFN-alpha in United States?

Active Biotech AB is the originator. The local marketing authorisation holder may differ — check the official source linked above.